Partner With Us.
G4A supports digital health companies through investments & commercial partnerships
Digital Health Partnerships
We provide investments for early-stage digital health companies & commercial partnership opportunities with Bayer for companies with a product or a solution already on the market.
Trust earned: What our partners say about us
Partnering with Bayer through the G4A programme has been a transformative experience. Their support has been instrumental in accelerating product development and helping us refine our strategy for market entry. The industry connections we gained have not only sharpened our approach but also opened up valuable opportunities for future collaboration. We are deeply grateful for their unwavering support and look forward to continued partnership.
Rewire Rehab Ltd is proud to be the winner of Bayer Pharmaceuticals 2024 grant for apps programme. The UK&I Digitial Health Team have been instrumental in building our NHS value proposition, including: market analysis, patient profiling and evidence generation. Bayer has also been a partner on two grants applications and has helped build brand awareness through their presence at national conferences. In short, the Digital Health Team at Bayer have helped to catalyse our growth, giving Rewire a platform to reduce post-stroke disability at scale.
The G4A team provided OKKO Health with an excellent foundation by navigating the emerging regulatory landscape and creating a business model that supports swift growth both within and beyond the pharmaceutical sector.
Partnering with Bayer through the G4A programme has been a transformative experience. Their support has been instrumental in accelerating product development and helping us refine our strategy for market entry. The industry connections we gained have not only sharpened our approach but also opened up valuable opportunities for future collaboration. We are deeply grateful for their unwavering support and look forward to continued partnership.
Rewire Rehab Ltd is proud to be the winner of Bayer Pharmaceuticals 2024 grant for apps programme. The UK&I Digitial Health Team have been instrumental in building our NHS value proposition, including: market analysis, patient profiling and evidence generation. Bayer has also been a partner on two grants applications and has helped build brand awareness through their presence at national conferences. In short, the Digital Health Team at Bayer have helped to catalyse our growth, giving Rewire a platform to reduce post-stroke disability at scale.
The G4A team provided OKKO Health with an excellent foundation by navigating the emerging regulatory landscape and creating a business model that supports swift growth both within and beyond the pharmaceutical sector.
Partnering with Bayer through the G4A programme has been a transformative experience. Their support has been instrumental in accelerating product development and helping us refine our strategy for market entry. The industry connections we gained have not only sharpened our approach but also opened up valuable opportunities for future collaboration. We are deeply grateful for their unwavering support and look forward to continued partnership.
Rewire Rehab Ltd is proud to be the winner of Bayer Pharmaceuticals 2024 grant for apps programme. The UK&I Digitial Health Team have been instrumental in building our NHS value proposition, including: market analysis, patient profiling and evidence generation. Bayer has also been a partner on two grants applications and has helped build brand awareness through their presence at national conferences. In short, the Digital Health Team at Bayer have helped to catalyse our growth, giving Rewire a platform to reduce post-stroke disability at scale.
Pitch Club become part of a unique community
